European Companies Search Engine
Registration · Managing Director: Frank Hübler, Martin Schwarz · Authorized signatory (ppa) (5) · Address · Capital: €25,000 · Shareholder agreement · Proxy policy · Corporate Purpose Hrb 19 Jan 2021 German Trade Register Announcements, Germany
Overview
Text
HRB 50119: Boehringer Ingelheim FinanzInvest GmbH, Ingelheim am
Unnamed street ??, 55216 Ingelheim a. Rhein, Germany
. LLC. Partnership agreement of 11 November 2020. Business address:
Unnamed street ??, 55216 Ingelheim a. Rhein, Germany
. Subject: Acquisition and disposal, holding and managing of fund shares and shareholdings. The Company may also operate in the pharmaceutical business, in particular by developing, manufacturing and distributing chemical or pharmaceutical products itself or by entrusting others with them. Share capital: EUR 25,000.00. General representation scheme: If only one managing director is appointed, he shall represent the company alone. If several directors are appointed, the company is represented by two directors or by a managing director together with an authorized representative. Managing Directors: Hübler, Frank, Sulzbach, *??.??.????; Dr. Schwarz, Martin, Mainz, *??.??.????. General prokura together with a managing director or other authorized representative: Bach, Stephan, Boppard, *??.??.????; Fidler, Malte, Frankfurt am Main, *??.??.????; Dr. Gann, Jochen, Bad Kreuznach, *??.??.????; Grupp, Clemens, Mainz, *??.??.????; Mauer, Martin, Bingen am Rhein, *??.??.????.
This filing was translated from German to English. The filing refers to a past date, and does not necessarily reflect the current state. The latest known state is available on the following page: Boehringer Ingelheim FinanzInvest GmbH, Ingelheim a. Rhein, Germany.